Mirjana Novković

Research Assistant

Institute of molecular genetics and genetic engineering (IMGGE),
University of Belgrade

V. Stepe 444a, P.Fah 23, 11010 Belgrade, Serbia
Mobile:    +381 65 397 66 58                          
Phone:    +381 11 397 66 58
Fax:        +381 11 397 58 08
E-mail: mirjananovkovic@imgge.bg.ac.rs


2012 - PhD student of Molecular biology of eukaryotes, Faculty of Biology (FB), University of Belgrade
2012 - Degree in biology, Faculty of Biology (FB), University of Belgrade (UB)


2012 - PhD student, Laboratory for Molecular Biology, IMGGE
2011- 2012 - research volonteer in Center for Human Molecular Genetics at Faculty of Biology


  • Biomarkers for human diseases.
  • Molecular genetics.
  • DNA analysis and molecular diagnostics.
  • Pharmacogenetics in cardiovascular diseases.
  • Regulation and expression of CYP2C9 and CYP2C19 genes.
  • Epigenetic regulation of gene expresion.


  • Novkovic M, Matic D, Kusic-Tisma J, Antonijevic N, Radojkovic D, Rakicevic L (2018) Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel. Eur J Clin Pharmacol 74 (4): 443-451 DOI 10.1007/s00228-017-2401-5
  • Mitropoulou C, Fragoulakis V, Rakicevic LB, Novkovic MM, Vozikis A, Matic DM, Antonijevic NM, Radojkovic DP, van Schaik RH, Patrinos GP (2016) Economic analysis of pharmacogenomic-guided clopidogrel treatment in Serbian patients with myocardial infarction undergoing primary percutaneous coronary intervention. Pharmacogenomics  DOI 10.2217/pgs-2016-0052
  • Backovic D, Ignjatovic S, Rakicevic L, Novkovic M, Kusic-Tisma J, Radojkovic D, Strugarevic E, Calija B, Radak D, Kovac M (2016) Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study. Curr Vasc Pharmacol 14 (6): 563-569

Please publish modules in offcanvas position.